Qian Dong
- Health Informatics top 10%
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
-
- Cancer, Hypoxia, and Metabolism 7
-
- Pancreatic and Hepatic Oncology Research 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
- Organ Transplantation Techniques and Outcomes 3
- Testicular diseases and treatments 3
- Bladder and Urothelial Cancer Treatments 3
-
- Neuroblastoma Research and Treatments 8
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Qian Dong
47 papers receiving 507 citations
Peers
Comparison fields: 5 of 105
- Health Informatics 14
- Hepatology 44
- Cancer Research 65
- Oncology 114
- Gastroenterology 22
Countries citing papers authored by Qian Dong
This map shows the geographic impact of Qian Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Dong more than expected).
Fields of papers citing papers by Qian Dong
This network shows the impact of papers produced by Qian Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Dong. The network helps show where Qian Dong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qian Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 1 | |
| 12 | 2016 | 9 | |
| 13 | 2014 | 38 | |
| 14 | CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. | 2014 | 16 |
| 15 | 2013 | 9 | |
| 16 | 2011 | 1 | |
| 17 | 2010 | 12 | |
| 18 | 2010 | 8 | |
| 19 | 2008 | 0 | |
| 20 | 2007 | 8 |
About Qian Dong
Qian Dong is a scholar working on Hepatology, Cancer Research and Neurology, having authored 54 papers that have together received 512 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Organ Transplantation Techniques and Outcomes (3 papers), Testicular diseases and treatments (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Health Informatics (14 citations), Hepatology (44 citations) and Cancer Research (65 citations). Qian Dong has collaborated with scholars based in China, United States and India. Frequent co-authors include Yang Liu, Rongxing Yi, Xiwei Hao, Hongting Lu, Haitao Niu, Zhiqiang Li, Bin Wei, Ge Guan, Xuecheng Yang and Bin Li. Their work appears in journals such as Scientific Reports, Medicine and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.